Experimental prescription, rising resistance: the alarming misuse of ceftazidime-avibactam in healthcare systems
No Abstract No Abstract No Abstract
Saved in:
Main Authors: | Mojtaba Akbari, Christian G Giske, Hamid Solgi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2024-12-01
|
Series: | Iranian Journal of Microbiology |
Subjects: | |
Online Access: | https://ijm.tums.ac.ir/index.php/ijm/article/view/5161 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating Gram-negative bacilli isolates’ sensitivity to ceftazidime/avibactam
by: Sunali, et al.
Published: (2025-01-01) -
Ceftazidime-avibactam susceptibility against Escherichia coli and Klebsiella pneumoniae
by: Arun Sachu, et al.
Published: (2025-02-01) -
Persistent Bacteremia from Pseudomonas aeruginosa with In Vitro Resistance to the Novel Antibiotics Ceftolozane-Tazobactam and Ceftazidime-Avibactam
by: Louie Mar Gangcuangco, et al.
Published: (2016-01-01) -
Global phylogeography and genetic characterization of carbapenem and ceftazidime-avibactam resistant KPC-33-producing Pseudomonas aeruginosa
by: Longjie Zhou, et al.
Published: (2025-01-01) -
Efficacy of ceftazidime-avibactam with or without polymyxin for carbapenem-resistant Klebsiella pneumoniae infections after initial treatment with polymyxin
by: Jingli Lu, et al.
Published: (2025-01-01)